Combec indications
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: Apply as a topical preparation at 3% or 3.5%.
Combec dosage
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: Apply as a topical preparation at 3% or 3.5%.
Combec interactions
May enhance the effects of oral anticoagulants, phenytoin and sulphonylureas. May increase plasma concentrations of lithium, methotrexate, and cardiac glycosides. Increased risk of hyperkalaemia with ACE inhibitors and potassium-sparing diuretics. May reduce antihypertensive action of some antihypertensives such as ACE inhibitors. May increase the risk of convulsions with quinolones.
Combec side effects
Photosensitivity, acute protocolitis, gastrointestinal discomfort, nausea, and diarrhoea
Potentially Fatal: Hypersensitivity and asthma.
Combec contraindications
Hypersensitivity to aspirin or any other NSAIDs. Porphyria, active peptic ulceration.
Active ingredient matches for Combec:
Flufenamic Acid in Japan.
List of Combec substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Achless | |
| Ansatin | |
| Ansuyan (Taiwan) | |
| Ansuyan 200 mg | |
| Arlef (Australia) | |
| Combec 5% (Japan) | |
| Dignodolin (Germany) | |
| Fenazol (Japan) | |
| Fenazol 5% (Japan) | |
| Flufacid | |
| Flufemin (Taiwan) | |
| Flufemin 100 mg | |
| Flufenamic Acid (Switzerland) | |
| Flufenamic Acid / M.T. 200 mg | |
|
sponsored
| |
| Flufenamic acid Honten (Taiwan) | |
| Flufenamic acid Ming Ta (Taiwan) | |
| Fluore-200 | |
| Fullsafe | |
| Kanyen (Taiwan) | |
| Kanyen 200 mg | |
| Lanceat | |
| Meralen | |
| Mobilat Intens Muskel und Gelenksalbe | |
| Ointment; Topical; Flufenamic Acid 3% | |
| Mobilisin (Portugal) | |
| Gel; Topical; Flufenamic Acid 3%; Glycol Salicylate 2.64%; Heparinoid 0.2%; Salicylic Acid 2% (Ciclum) | |
| Mobilisin Plus (Austria) | |
| Nichisedan | |
| Opaferumin (Japan) | |
| Opyrin (Japan) | |
| Parlef | |
| Parlif | |
| Plostene | |
| Reumajust A | |
| Rheuma Lindofluid (Germany) | |
| Ristogen | |
| Saal-F | |
| Sastridex (Germany) | |
| Surika | |
| Suyanlen (Taiwan) | |
| Suyanlen 100 mg | |
| Tecramine | |
| Tonti (Taiwan) | |
| Tonti 100 mg | |
| Youfenil (Japan) | |
References
- PubChem. "flufenamic acid". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "flufenamic acid". http://www.drugbank.ca/drugs/DB02266 (accessed September 17, 2018).
- DTP/NCI. "flufenamic acid: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Combec are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Combec. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet1 consumer reported age
| Users | % | ||
|---|---|---|---|
| 16-29 | 1 | 100.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
